Potential Uses of Nanotechnology in Healthcare: Nanotechnology's Unique Properties as a Diagnostic Tool and Medical Domain

Abstract

Nanomedicine exists as one main healthcare field which benefits from nanotechnology applications.  Various nanotechnology-based diagnostic and imaging tools together with pharmaceutical products alongside biomedical implants and targeted medicinal treatments and tissue engineering applications and several nanoparticles serve these healthcare fields.  Nanotechnology enables high toxicity therapeutic cancer drugs and other treatments to receive improved safety profiles during administration.  Wearable technology has the ability to detect critical indicator changes and cancer cell states and infections during real-time monitoring.  These technologies situated in the fundamental problem will make essential data about vital sign changes and sickness causes readily accessible to doctors.  Bioinformatics through predictive analytics technology enables solutions for medical treatments.  The authors researched medical nanotechnology-related papers by investigating Scopus, Google Scholar, ResearchGate along with additional research platforms.  The study investigates all applications of nanoparticles throughout medical practices.  The medical applications of nanotechnology form the core focus in this research work.  The second section introduces the medical aspects of nanotechnology by discussing its medical features together with its properties.  The steering of nanotechnology development in specific domains requires collaboration between experts from academic, governmental and public sectors.  This research evaluates numerous medical applications which nanotechnology can enable.  The endocrine system regulates multiple body processes through its control mechanism while diabetes along with thyroid problems and Cushing's syndrome and obesity develop due to its disturbances.  Close to fifty percent of participants developed fresh endocrine conditions leading to an overall medical diagnosis rate of 47.4% without treating type 2 diabetes mellitus.  Nanotechnology has created new investigative possibilities for studying disease causes and treatments because its atomic and molecular particle manipulation approach.  Reaching the end goal in developing nano-biosensors for endocrine treatment requires them to automatically detect minor hormone fluctuations while restoring balanced body system.  The unique surface character together with reduced dimensions of nanoparticles makes them valuable agents for targeted drug transportation and more sensitive sensor design.  Nano-scale drug delivery carriers made from lipids and polymers together with carbon and metals demonstrate superior performance compared to traditional delivery systems.  Nanoparticles serve medical benefits as hydrogels for insulin delivery as well as wound treatment while providing superior outcomes compared to traditional endocrine diagnosis and management methods.  The bioactivity together with targeted delivery of inorganic nanoparticles experiences enhanced performance through inclusion of selenium NPs.  Research indicates that insulin delivery through gold nanoparticles has the potential to succeed.  The incorporation of lipid and polymeric NPs along with mesoporous silica NPs gives healthcare professionals a way to protect medications from gastrointestinal destruction for effective glycaemic level management.  Thyroid procedures have increasingly adopted carbon nanotubes (CNTs) during the recent period.  Engineers find special attributes of diagnostic and therapeutic systems attractive because these systems include nanoparticles.  The development of drug formulations through nanoparticle technology has established medical opportunities for treating resistant medical conditions.  Size definitions for nanoparticles extend from 100 to 500 nm with certain exceptions from this range.  Nanoparticles become smart systems when their size combination joins with surface modifications to their base material. The stealth-enabled systems have storage space for both therapeutic and imaging agents.  These systems provide therapeutic drug containment and regional drug delivery strategies through controlled medication release systems.  By continuously delivering medication through this specific system patients become more likely to follow their prescribed treatments and encounter lower numbers of adverse drug reactions.  Nanotechnology advances both diagnostic assessments and exhibits potential to treat cancer in combination with AIDS while addressing multiple other healthcare conditions.